Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.

Bosentan alleviates the pro-fibrotic phenotype of lung scleroderma fibroblasts: Implications for treatment of scleroderma.

Библиографические подробности
Главные авторы:	Leask, A, Xu, S, Renzoni, E, Bou-Gharios, G, du Bois, R, Abraham, D, Black, C
Формат:	Conference item
Опубликовано:	2005

Схожие документы

Bosentan attenuates the profibrotic gene expression profile of lung fibroblasts in scleroderma
по: Shiwen, X, и др.
Опубликовано: (2006)

Effects of bosentan on collagen type I synthesis on in vitro culture of scleroderma skin fibroblasts
по: S. Soldano, и др.
Опубликовано: (2011-01-01)

Successful Treatment with Bosentan of Lower Extremity Ulcers in a Scleroderma Patient
по: Alix Naert, и др.
Опубликовано: (2013-01-01)

CTGF overexpressing mice: a model for human scleroderma
по: Sonnylal, S, и др.
Опубликовано: (2006)

Bosentan Does Not Affect Renal Resistive Index in Scleroderma/Systemic Sclerosis Patients
по: Emma Di Poi, и др.
Опубликовано: (2023-11-01)

Scleroderma with Nodular Scleroderma
по: Chutika Srisuttiyakorn, и др.
Опубликовано: (2016-11-01)

Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts.
по: Shi-Wen, X, и др.
Опубликовано: (2007)

Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts.
по: Shi-Wen, X, и др.
Опубликовано: (2004)

Scleroderma and scleroderma-like syndromes
по: Katarzyna Romanowska-Próchnicka, и др.
Опубликовано: (2024-06-01)

Corrigendum: Scleroderma and Scleroderma-like syndromes
по: Katarzyna Romanowska-Próchnicka, и др.
Опубликовано: (2024-07-01)

Paraneoplastic scleroderma or neoplasia secondary to scleroderma
по: Alexandru Arvunescu, и др.
Опубликовано: (2019-12-01)

Antifibrotic effects of roscovitine in normal and scleroderma fibroblasts.
по: Richard A Steinman, и др.
Опубликовано: (2012-01-01)

Checkpoint Inhibitor-Associated Scleroderma and Scleroderma Mimics
по: Michael Macklin, и др.
Опубликовано: (2023-02-01)

Use of Patterned Collagen Coated Slides to Study Normal and Scleroderma Lung Fibroblast Migration
по: Bahja Ahmed Abdi, и др.
Опубликовано: (2017-06-01)

Scleroderma as a paraneoplastic syndrome and tumors associated with scleroderma
по: N. A. Shostak, и др.
Опубликовано: (2020-05-01)

Keloids in scleroderma-keloidal scleroderma: A unique entity
по: Sumit Sen, и др.
Опубликовано: (2013-01-01)

The Anti-Fibrotic Effect of Cold Atmospheric Plasma on Localized Scleroderma In Vitro and In Vivo
по: Stephanie Arndt, и др.
Опубликовано: (2021-10-01)

Intramuscular Polydeoxyribonucleotides in Fibrotic and Atrophic Localized Scleroderma: An Explorative Prospective Cohort Study
по: Maurizio Romagnuolo, и др.
Опубликовано: (2023-04-01)

Genetics of scleroderma: implications for personalized medicine?
по: Assassi Shervin, и др.
Опубликовано: (2013-01-01)

Mimics of scleroderma
по: Kaveri K Nalianda, и др.
Опубликовано: (2017-01-01)

The pathogenesis of scleroderma
по: Latika Gupta, и др.
Опубликовано: (2017-01-01)

Rac inhibition reverses the phenotype of fibrotic fibroblasts.
по: Shi-wen Xu, и др.
Опубликовано: (2009-10-01)

Response of human lung fibroblast cells to stimulation by endothelin-1: Involvement of ras/MEK/ERK and PI3 kinase
по: Shiwen, X, и др.
Опубликовано: (2003)

Endothelin is a downstream mediator of profibrotic responses to transforming growth factor beta in human lung fibroblasts.
по: Shi-wen, X, и др.
Опубликовано: (2007)

OVERDENTURE IN SCLERODERMA'S PATIENT
по: , Elin Hertiana
Опубликовано: (2012)

GI Manifestation in Scleroderma
по: Chingching Foocharoen
Опубликовано: (2024-01-01)

Phaeochromocytoma Mimicking Scleroderma
по: Joan Joo-Ching Khoo, и др.
Опубликовано: (2011-01-01)

Treatment for systemic scleroderma
по: Rezvaya Tairovich Alekperov, и др.
Опубликовано: (2011-09-01)

Scleroderma and related disorders
по: Anupam Wakhlu, и др.
Опубликовано: (2017-01-01)

Thelytoky in Scleroderma Immigrans
по: Clyde E. Keeler
Опубликовано: (1929-01-01)

Human otopathology in scleroderma
по: Melissa Castillo‐Bustamante, и др.
Опубликовано: (2023-12-01)

Finger Printlessness in Scleroderma
по: Milad HOSSEINIALHASHEMI, и др.
Опубликовано: (2016-08-01)

Scleroderma lung disease
по: Joshua J. Solomon, и др.
Опубликовано: (2013-03-01)

Scleroderma renal crisis
по: Gioacchino Li Cavoli, и др.
Опубликовано: (2018-01-01)

Purtscher’s retinopathy in scleroderma
по: Alzahrani, Mazen, и др.
Опубликовано: (2019-03-01)

Treatment for systemic scleroderma
по: Rezvaya Tairovich Alekperov, и др.
Опубликовано: (2011-09-01)

Localized scleroderma in children
по: Katarzyna A. Wolska-Gawron, и др.
Опубликовано: (2020-06-01)

Scleroderma-related choroiditis
по: Parthopratim Dutta Majumder, и др.
Опубликовано: (2018-01-01)

Single-Cell Analysis of ADSC Interactions with Fibroblasts and Endothelial Cells in Scleroderma Skin
по: Marvin L. Frommer, и др.
Опубликовано: (2023-07-01)

Scleroderma of geriatric age and scleroderma-like paraneoplastic syndrome – description of two cases
по: Magdalena Marek, и др.
Опубликовано: (2016-06-01)